Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
USP6NL antisense RNA 1 (**USP6NL-AS1**) is a long noncoding RNA gene localized to human chromosome 10p14. It is transcribed in an antisense orientation to the *USP6NL* protein-coding gene but does not encode a protein. Its precise biological function, pathology relevance, and biomarker status remain undetermined in the published scientific literature. There are no reports of interaction with drugs, nor is USP6NL-AS1 currently considered a direct therapeutic target in clinical practice or research.
None applicable, as there are no drugs targeting USP6NL-AS1
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on USP6NL antisense RNA 1 (USP6NL-AS1).